Go Pro
→ Iran War WARNING: Something Just Changed (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$59.96
+1.9%		$46.26
$25.36
▼
$61.48
$2.99B1.261.40 million shs1.21 million shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$73.87
-1.8%		$79.87
$54.15
▼
$101.40
$10.10B0.951.37 million shs1.46 million shs
Insulet Corporation stock logo
PODD
Insulet
$136.49
-2.1%		$149.11
$126.40
▼
$354.88
$9.67B1.081.72 million shs1.02 million shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$26.83
-2.5%		$29.49
$26.69
▼
$37.51
$11.55B0.551.83 million shs1.79 million shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
+1.92%+4.94%+21.67%+113.15%+63.65%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-2.07%-1.90%-12.18%-12.58%+30.11%
Insulet Corporation stock logo
PODD
Insulet
-2.07%-2.92%-6.14%-11.27%-58.36%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
-2.41%-3.56%-9.48%-11.25%-25.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$59.96
+1.9%		$46.26
$25.36
▼
$61.48
$2.99B1.261.40 million shs1.21 million shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$73.87
-1.8%		$79.87
$54.15
▼
$101.40
$10.10B0.951.37 million shs1.46 million shs
Insulet Corporation stock logo
PODD
Insulet
$136.49
-2.1%		$149.11
$126.40
▼
$354.88
$9.67B1.081.72 million shs1.02 million shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$26.83
-2.5%		$29.49
$26.69
▼
$37.51
$11.55B0.551.83 million shs1.79 million shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
+1.92%+4.94%+21.67%+113.15%+63.65%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-2.07%-1.90%-12.18%-12.58%+30.11%
Insulet Corporation stock logo
PODD
Insulet
-2.07%-2.92%-6.14%-11.27%-58.36%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
-2.41%-3.56%-9.48%-11.25%-25.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.75
Moderate Buy$53.30-11.11% Downside
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.88
Moderate Buy$101.7737.77% Upside
Insulet Corporation stock logo
PODD
Insulet
2.42
Hold$195.4043.16% Upside
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$31.9118.96% Upside

Current Analyst Ratings Breakdown

Latest ATRC, SNN, GMED, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Insulet Corporation stock logo
PODD
Insulet
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
9/18/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
9/17/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$65.00
9/11/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$33.88
9/8/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
9/8/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Neutral
9/4/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
9/2/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$45.00 ➝ $64.00
9/2/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight
8/31/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral
8/27/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$50.00 ➝ $60.00
(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M5.71$0.32 per share187.96$9.89 per share6.06
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.94B3.37$6.17 per share11.97$33.86 per share2.18
Insulet Corporation stock logo
PODD
Insulet
$2.71B3.50$6.19 per share22.04$21.54 per share6.34
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$6.16B1.83$3.34 per share8.02$12.45 per share2.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M$0.21285.54133.24N/A1.85%2.34%1.77%11/4/2026 (Estimated)
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$3.9118.8913.701.2117.02%14.57%12.62%11/5/2026 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$247.10M$5.3525.5117.731.1012.29%29.29%13.31%11/5/2026 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$625MN/AN/A11.611.49N/AN/AN/AN/A

Latest ATRC, SNN, GMED, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.10$1.34+$0.24$1.10$782.88 million$789.61 million
8/5/2026Q2 2026
Insulet Corporation stock logo
PODD
Insulet
$1.47$1.66+$0.19$1.37$787.39 million$801.70 million
7/23/2026Q2 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.0017$0.18+$0.1817$0.18$151.80 million$153.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.933.47%N/AN/AN/A

Latest ATRC, SNN, GMED, and PODD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.31202.05%10/2/202610/2/202611/6/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.14
4.22
3.19
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.62
2.93
Insulet Corporation stock logo
PODD
Insulet
0.65
2.48
1.83
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.14
1.11

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Insulet Corporation stock logo
PODD
Insulet
N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
Insulet Corporation stock logo
PODD
Insulet
0.36%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,35050.87 million48.83 millionOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000134.26 million109.59 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.35 million69.10 millionOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
16,988419.93 million415.73 millionOptionable

Recent News About These Companies

Il titolo azionario di Smith & Nephew tocca il minimo a 52 settimane a 27,05 USD
September 23 at 6:10 PM  |  it.investing.comhttps://it.investing.com/news/company-news/il-titolo-azionario-di-smith--nephew-tocca-il-minimo-a-52-settimane-a-2705-usd-93CH-3559786
Smith & Nephew Snats (SNN) Gets a Hold from BTIG
September 23 at 6:10 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SNN/pressreleases/4752259/smith-nephew-snats-snn-gets-a-hold-from-btig/
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
September 23 at 12:01 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/23/3367719/0/en/multimedia-update-smith-nephew-launches-the-new-evos-pelvic-plating-system-at-the-2026-orthopedic-trauma-association-ota-annual-meeting-expanding-the-evos-plating-platform-for-pelv.html
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
September 23 at 11:11 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/23/3367649/0/en/smith-nephew-launches-the-new-evos-pelvic-plating-system-at-the-2026-orthopedic-trauma-association-ota-annual-meeting-expanding-the-evos-plating-platform-for-pelvic-and-acetabular-.html
Smith & Nephew SNATS (NYSE:SNN) Sets New 12-Month Low - Time to Sell?
September 23 at 10:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-smith-nephew-snats-nyse-snn-sets-new-12-month-low-time-to-sell-2026-09-23/
Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Average Recommendation of "Hold" from Analysts
September 22 at 4:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-smith-nephew-snats-inc-nyse-snn-receives-average-recommendation-of-hold-from-analysts-2026-09-22/
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
September 21 at 10:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/21/3365585/0/en/smith-nephew-to-showcase-leading-shoulder-technologies-for-joint-repair-and-reconstruction-at-icses-2026.html
1,550,110 Shares in Smith & Nephew SNATS, Inc. $SNN Bought by Bank of America Corp DE
September 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-1550110-shares-in-smith-nephew-snats-inc-snn-bought-by-bank-of-america-corp-de-2026-09-19/
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds
September 16, 2026  |  accessnewswire.comA
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds
September 15, 2026  |  accessnewswire.comA
Is It Too Late to Buy Smith & Nephew PLC (SNN) After 3.3% Rally? GF Value Says Undervalued
September 14, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9080445/is-it-too-late-to-buy-smith-nephew-plc-snn-after-33-rally-gf-value-says-undervalued
Smith & Nephew SNATS, Inc. $SNN Shares Acquired by Tidal Investments LLC
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-smith-nephew-snats-inc-snn-shares-acquired-by-tidal-investments-llc-2026-09-13/
Smith & Nephew SNATS (NYSE:SNN) Upgraded to "Buy" at Wall Street Zen
September 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31019592
Wall Street Zen Upgrades Smith & Nephew SNATS (NYSE:SNN) to "Buy"
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-wall-street-zen-upgrades-smith-nephew-snats-nyse-snn-to-buy-2026-09-13/
Smith & Nephew Raises $700 Million in 10‑Year U.S. Dollar Notes
September 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SNN/pressreleases/4565277/smith-nephew-raises-700-million-in-10year-us-dollar-notes/
Smith & Nephew SNATS (NYSE:SNN) Stock Rating Upgraded by Zacks Research
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-smith-nephew-snats-nyse-snn-stock-rating-upgraded-by-zacks-research-2026-09-10/
Smith & Nephew SNATS (NYSE:SNN) Hits New 52-Week Low Following Analyst Downgrade
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-smith-nephew-snats-nyse-snn-hits-new-52-week-low-following-analyst-downgrade-2026-09-09/
Smith & Nephew SNATS (NYSE:SNN) Sees Strong Trading Volume - Here's Why
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-smith-nephew-snats-nyse-snn-sees-strong-trading-volume-heres-why-2026-09-08/
Smith & Nephew SNATS (NYSE:SNN) Rating Lowered to "Neutral" at Bank of America
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-smith-nephew-snats-nyse-snn-rating-lowered-to-neutral-at-bank-of-america-2026-09-08/
Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m
September 8, 2026  |  accessnewswire.comA
Public Employees Retirement System of Ohio Invests $2.17 Million in Smith & Nephew SNATS, Inc. $SNN
September 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-invests-217-million-in-smith-nephew-snats-inc-snn-2026-09-07/

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$59.96 +1.13 (+1.92%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$59.45 -0.51 (-0.85%)
As of 09/23/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Globus Medical stock logo

Globus Medical NYSE:GMED

$73.87 -1.32 (-1.76%)
Closing price 09/23/2026 03:59 PM Eastern
Extended Trading
$73.94 +0.07 (+0.10%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Insulet stock logo

Insulet NASDAQ:PODD

$136.49 -2.89 (-2.07%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$135.46 -1.04 (-0.76%)
As of 09/23/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$26.82 -0.68 (-2.45%)
Closing price 09/23/2026 03:59 PM Eastern
Extended Trading
$26.82 -0.01 (-0.04%)
As of 09/23/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas